Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668966 | SCV000793651 | pathogenic | Bloom syndrome | 2017-08-22 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000668966 | SCV002018451 | pathogenic | Bloom syndrome | 2019-09-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000668966 | SCV002237132 | pathogenic | Bloom syndrome | 2023-07-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys662Ilefs*5) in the BLM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID: 17407155). This variant is present in population databases (rs762804291, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with BLM-related conditions (PMID: 24118499). ClinVar contains an entry for this variant (Variation ID: 553499). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000668966 | SCV004210904 | pathogenic | Bloom syndrome | 2023-11-18 | criteria provided, single submitter | clinical testing |